Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study

Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)

NCT04229901 ·Status: TERMINATED ·Phase: PHASE2

To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).

NCT03162419 ·Status: WITHDRAWN ·Phase: NA

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116 ·Status: COMPLETED ·Phase: PHASE2

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

NCT00225901 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients

NCT03882346 ·Status: UNKNOWN ·Phase: PHASE2

Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome

NCT07276568 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1

A-TANGO Phase 2 Study

NCT06890039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid

NCT02442180 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.

NCT04066179 ·Status: UNKNOWN ·Phase: NA

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Liver Regeneration With Autologous Peripheral Stem Cells

NCT01108380 ·Status: UNKNOWN ·Phase: NA

Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells

NCT01062750 ·Status: COMPLETED ·Phase: NA

Norursodeoxycholic Acid vs. Placebo in NASH

NCT05083390 ·Status: RECRUITING ·Phase: PHASE2

Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology

NCT05605821 ·Status: NOT_YET_RECRUITING

NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)

NCT03968354 ·Status: UNKNOWN

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

NCT05309642 ·Status: COMPLETED ·Phase: NA

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

NCT02026401 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

NCT02029586 ·Status: TERMINATED ·Phase: PHASE2

Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients

NCT03963921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

NCT05632861 ·Status: RECRUITING ·Phase: PHASE2

Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

NCT00802555 ·Status: COMPLETED ·Phase: PHASE1

The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis

NCT01741090 ·Status: UNKNOWN ·Phase: PHASE2

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

NCT02868164 ·Status: WITHDRAWN ·Phase: NA

Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease

NCT01315795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells

NCT00913289 ·Status: TERMINATED ·Phase: PHASE1